Control of experimental autoimmune encephalomyelitis by CD4+ suppressor T cells: Peripheral versus in situ immunoregulation
- 1 November 2007
- journal article
- review article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 191 (1-2) , 61-69
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitisJournal of Clinical Investigation, 2006
- Modulating CCR2 and CCL2 at the blood–brain barrier: relevance for multiple sclerosis pathogenesisBrain, 2005
- New IL-12-family members: IL-23 and IL-27, cytokines with divergent functionsNature Reviews Immunology, 2005
- IL-23 drives a pathogenic T cell population that induces autoimmune inflammationJournal of Experimental Medicine, 2005
- Frontline: Neuropilin‐1: a surface marker of regulatory T cellsEuropean Journal of Immunology, 2004
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- Regulatory T Cell Clones Induced by Oral Tolerance: Suppression of Autoimmune EncephalomyelitisScience, 1994
- The Wisdom of HindsightAnnual Review of Immunology, 1994
- The immune system evolved to discriminate infectious nonself from noninfectious selfImmunology Today, 1992